Total Payments
$9,755
2024 Payments
$1,884
Companies
36
Transactions
643
Medicare Patients
5,705
Medicare Billing
$626,624
Payment Breakdown by Category
Food & Beverage$9,656 (99.0%)
Education$99.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,656 | 642 | 99.0% |
| Education | $99.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,850 | 180 | $0 (2024) |
| Janssen Biotech, Inc. | $1,687 | 126 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,079 | 60 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $804.26 | 53 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $516.05 | 42 | $0 (2024) |
| Allergan Inc. | $348.69 | 33 | $0 (2019) |
| Braintree Laboratories, Inc. | $227.85 | 15 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $210.21 | 13 | $0 (2017) |
| Gilead Sciences, Inc. | $193.82 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $154.11 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,884 | 113 | ABBVIE INC. ($616.47) |
| 2023 | $1,688 | 103 | AbbVie Inc. ($574.45) |
| 2022 | $1,392 | 87 | ABBVIE INC. ($516.15) |
| 2021 | $1,242 | 81 | Janssen Biotech, Inc. ($505.16) |
| 2020 | $455.14 | 28 | AbbVie Inc. ($139.70) |
| 2019 | $804.03 | 59 | AbbVie, Inc. ($200.25) |
| 2018 | $932.53 | 72 | AbbVie, Inc. ($265.49) |
| 2017 | $1,359 | 100 | AbbVie, Inc. ($265.05) |
All Payment Transactions
643 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Immunology | ||||||
| 11/25/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: GI | ||||||
| 11/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: GI | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: GI | ||||||
| 11/14/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Immunology | ||||||
| 11/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $45.24 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.83 | General |
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: GI | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,415 | 1,564 | $827,275 | $158,086 |
| 2022 | 16 | 1,397 | 1,546 | $841,283 | $155,724 |
| 2021 | 17 | 1,522 | 1,661 | $921,903 | $169,436 |
| 2020 | 13 | 1,371 | 1,550 | $788,098 | $143,377 |
Total Patients
5,705
Total Services
6,321
Medicare Billing
$626,624
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 210 | 211 | $213,110 | $26,684 | 12.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 252 | 256 | $197,632 | $24,742 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 256 | $49,920 | $24,286 | 48.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 109 | 110 | $102,850 | $22,005 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $25,688 | $12,491 | 48.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 81 | $24,786 | $11,100 | 44.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 172 | $18,920 | $10,712 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 97 | $13,289 | $6,195 | 46.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 77 | 78 | $69,966 | $4,692 | 6.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 24 | 26 | $18,148 | $4,508 | 24.8% |
| 43450 | Dilation of esophagus | Facility | 2023 | 116 | 117 | $44,226 | $3,663 | 8.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 24 | 25 | $17,450 | $3,239 | 18.6% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $22,848 | $2,484 | 10.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $8,442 | $1,286 | 15.2% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 232 | 232 | $234,320 | $29,372 | 12.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 122 | 122 | $114,070 | $25,243 | 22.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 239 | 251 | $193,772 | $24,838 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 175 | $34,125 | $15,914 | 46.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 96 | 97 | $29,682 | $14,990 | 50.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 219 | $24,090 | $12,107 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 117 | $16,029 | $7,858 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $14,820 | $7,136 | 48.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 27 | 28 | $19,544 | $4,921 | 25.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 67 | 67 | $60,099 | $4,176 | 6.9% |
| 43450 | Dilation of esophagus | Facility | 2022 | 104 | 108 | $40,824 | $3,359 | 8.2% |
About Dr. Donald Denby, M.D
Dr. Donald Denby, M.D is a Gastroenterology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912984972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Denby, M.D has received a total of $9,755 in payments from pharmaceutical and medical device companies, with $1,884 received in 2024. These payments were reported across 643 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($9,656).
As a Medicare-enrolled provider, Denby has provided services to 5,705 Medicare beneficiaries, totaling 6,321 services with total Medicare billing of $626,624. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Pensacola, FL
- Active Since 12/29/2005
- Last Updated 04/17/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1912984972
Products in Payments
- STELARA (Biological) $1,602
- RINVOQ (Biological) $649.27
- Linzess (Drug) $626.40
- ENTYVIO (Biological) $542.03
- LINZESS (Drug) $481.39
- XIFAXAN (Drug) $443.29
- VIBERZI (Drug) $371.13
- SKYRIZI (Biological) $363.66
- Humira (Biological) $317.74
- CREON (Drug) $309.79
- GATTEX (Drug) $291.30
- MAVYRET (Drug) $235.38
- Mavyret (Drug) $214.30
- HUMIRA (Biological) $188.01
- SUPREP (Drug) $187.10
- TRULANCE (Drug) $160.01
- DUPIXENT (Biological) $144.72
- Trulance (Drug) $144.58
- OCALIVA (Drug) $144.40
- Amitiza (Drug) $134.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Pensacola
Dr. Benjamin Tharian, Md Mrcp Fracp, MD MRCP FRACP
Gastroenterology — Payments: $42,592
Gastroenterology $42,592
Frederic Newman, Md, MD
Gastroenterology — Payments: $32,704
Gastroenterology $32,704
Dr. Michael Zelig, Md, MD
Gastroenterology — Payments: $10,262
Gastroenterology $10,262
Dr. Ronald Powell, Md, MD
Gastroenterology — Payments: $8,112
Gastroenterology $8,112
Patrick Reilly, Md, MD
Gastroenterology — Payments: $6,928
Gastroenterology $6,928
Dr. Samer Al-Shurieki, Md, MD
Gastroenterology — Payments: $6,794
Gastroenterology $6,794